SRPT vs STIM · rev $1.13B vs rev $76.0M
Sarepta Therapeutics Inc (SRPT) versus Neuronetics Inc (STIM) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Neuronetics Inc (STIM) is a medical devices company listed on NASDAQ.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
Latest reported STIM revenue for 2026-06-30 was $76.0M. Net income was -$14.2M. STIM currently screens at market cap $84.2M.
SRPT currently screens at market cap $2.34B. STIM currently screens at market cap $84.2M.
Not investment advice. Open the SRPT and STIM stock pages for the full models.
Not investment advice.